Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies

被引:32
|
作者
Cheng, Xiangming [1 ]
Gan, Weidong [1 ]
Zhang, Gutian [1 ]
Li, Xiaogong [1 ]
Guo, Hongqian [1 ]
机构
[1] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China
来源
BMC UROLOGY | 2016年 / 16卷
基金
中国国家自然科学基金;
关键词
Age groups; Carcinoma; Gender identity; Renal cell; Xp11.2; translocation; APART FISH ASSAY; AGGRESSIVE COURSE; ADULTS; CHILDREN; EXPERIENCE; DIAGNOSIS; FEATURES;
D O I
10.1186/s12894-016-0154-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) is a rare subtype of RCC which is firstly described as a distinct entity in 2004 so that clinical characteristics of Xp11.2 RCC in different gender and age are unknown. The purpose of systematic review and meta-analysis is to provide a comprehensive assessment on them. Methods: MEDLINE, EMBASE and Cochrane databases were searched for studies which evaluate the clinical characteristics of Xp11.2 RCC. The literature published between July 2004 and May 2014 was searched. Results: A total of 15 studies with 147 participants were included. The meta-analysis demonstrated that number of patients of all age in female was higher than in male with pooled OR of 3.93(95 % CI = 1.66-9.34). However, incidence of distant metastases (OR = 0.34, 95 % CI = 0.12-1.57) and lymphatic metastases (OR = 0.51, 95 % CI = 0.14-1.91), tumor stage (OR = 0.85, 95 % CI = 0.34-2.15) and overall survival (OS) (OR = 0.46, 95 % CI = 0.05-4.34) between male and female were comparable. Incidence in female was higher than in male with pooled OR of 5.13(95 % CI = 1.67-15.72) in adults, while in children no gender-related predominance (OR = 1.19, 95 % CI = 0.38-3.72) was observed. In addition, incidence of distant metastases (OR = 1.00, 95 % CI = 0.13-7.84) and lymphatic metastases (OR = 1.00, 95 % CI = 0.07-13.67) and tumor stage (OR = 1.94, 95 % CI = 0.20-19.03) between children and adults were comparable. Survival curves presented comparable outcomes between male and female (P = 0.707) as well as between children and adults (P = 0.383). Conclusions: Female patients with Xp11.2 RCC in adults exhibit a high incidence compared to male, but not in children. Comparable clinical characteristics including incidence of distant and lymphatic metastases, tumor stage and prognosis is presented between male and female as well as between children and adults.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma
    Zhu, Qing-Qiang
    Wang, Zhong-Qiu
    Zhu, Wen-rong
    Chen, Wen-xin
    Wu, Jing-tao
    ACTA RADIOLOGICA, 2013, 54 (03) : 355 - 362
  • [32] Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
    Agizamhan, Sezim
    Qu, Feng
    Liu, Ning
    Sun, Jing
    Xu, Wei
    Zhang, Lihua
    Guo, Hongqian
    Gan, Weidong
    BMC UROLOGY, 2018, 18
  • [33] Xp11.2 translocation renal cell carcinoma with SFPQ/PSF-TFE3 fusion gene: A case report with unusual histopathologic findings
    Ishikawa, Noriyoshi
    Nagase, Mamiko
    Takami, Saki
    Nagano, Nahoko
    Araki, Asuka
    Iwahashi, Teruaki
    Yamauchi, Naotaka
    Yamasaki, Taku
    Shiina, Hiroaki
    Maruyama, Riruke
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (09)
  • [34] Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma
    Pradhan, Dinesh
    Roy, Somak
    Quiroga-Garza, Gabriela
    Cieply, Kathleen
    Mahaffey, Alyssa L.
    Bastacky, Sheldon
    Dhir, Rajiv
    Parwani, Anil V.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [35] TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation-associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone Expanding the Morphologic Spectrum
    Rao, Qiu
    Williamson, Sean R.
    Zhang, Shaobo
    Eble, John N.
    Grignon, David J.
    Wang, Mingsheng
    Zhou, Xiao-jun
    Huang, Wenbin
    Tan, Puay-Hoon
    MacLennan, Gregory T.
    Cheng, Liang
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (06) : 804 - 815
  • [36] XP11.2 Translocation renal cell carcinoma: Clinical experience of Taipei Veterans General Hospital
    Hung, Chia-Chen
    Pan, Chin-Chen
    Lin, Chih-Chieh
    Lin, Alex T. L.
    Chen, Kuang-Kuo
    Chang, Yen-Hwa
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2011, 74 (11) : 500 - 504
  • [37] Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review
    Zhuang, Wenyuan
    Liu, Ning
    Guo, Hongqian
    Zhang, Chunni
    Gan, Weidong
    BMC UROLOGY, 2020, 20 (01)
  • [38] ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma
    Zhu, Yiqi
    Liu, Ning
    Guo, Wei
    Pu, Xiaohong
    Guo, Hongqian
    Gan, Weidong
    Li, Dongmei
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (12)
  • [39] Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review
    Yang, Denghao
    Tang, Wen
    Liu, Mingwen
    Xie, Zhifei
    Shi, Fei
    Zhao, Zeju
    Yang, Xiaorong
    Wu, Tao
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [40] Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
    He, Jian
    Zhou, Kefeng
    Zhu, Bin
    Zhang, Gutian
    Li, Xiaogong
    Guo, Hongqian
    Gan, Weidong
    Zhou, Zhengyang
    Liu, Tian
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015